Trial intelligence / Profile preview

Coated Suppositories for Anal Pressure in Healthy Subjects

NCT01265485Phase 2Completed

Sponsor
RDD Pharma
Start
Aug 2011
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of phenylephrine in fecal incontinence (FI), sponsored by RDD Pharma. Started Aug 2011; status: completed.

02

Drugs

phenylephrine
03

Conditions

fecal incontinence (FI)

Beyond the preview

Go deeper on NCT01265485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01265485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call